PREDICTING MINS WITH FRAILTY AND BIOMARKERS IN GERIATRIC SURGERY
THE ROLE OF FRAILTY INDICES AND PREOPERATIVE BIOMARKERS IN PREDICTING MYOCARDIAL INJURY AFTER NON-CARDIAC SURGERY IN ELDERLY ORTHOPEDIC PATIENTS: A MACHINE LEARNING ANALYSIS
1 other identifier
observational
600
1 country
1
Brief Summary
The primary objective of this study is to develop and validate a machine learning model that integrates preoperative clinical data, biomarkers, and modified frailty indices (mFI-5) to accurately predict myocardial injury after non-cardiac surgery (MINS) in geriatric patients ($\\ge$65 years) undergoing major orthopedic surgery and requiring postoperative intensive care. The research aims to compare the predictive performance of advanced algorithms, such as XGBoost and Random Forest, against traditional clinical risk scores like the Revised Cardiac Risk Index (RCRI), while specifically evaluating the impact of frailty on the model's area under the curve (AUC). Furthermore, by identifying the most critical preoperative predictors, this study seeks to establish an objective clinical decision support mechanism to guide clinicians in the early risk stratification of high-risk geriatric patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2026
CompletedFirst Submitted
Initial submission to the registry
April 23, 2026
CompletedFirst Posted
Study publicly available on registry
May 4, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 5, 2026
May 4, 2026
April 1, 2026
2 months
April 23, 2026
April 30, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of Myocardial Injury after Non-cardiac Surgery (MINS)
The area under the receiver operating characteristic curve (AUC-ROC) ,Percentage of participants)
30 days postoperatively
Secondary Outcomes (3)
Comparison of Machine Learning Models vs. Traditional Risk Scores (RCRI).
Up to 30 days post-surgery
Identification and ranking of the most significant preoperative predictors for MINS.
Through study completion, an average of 6 months
Identification and ranking of the most significant preoperative predictors for MINS
Through study completion, an average of 1 year
Study Arms (1)
Geriatric Orthopedic Surgery Patients
Geriatric patients aged 65 years and older who undergo major orthopedic surgery and are followed in the postoperative intensive care unit. This cohort includes patients evaluated for myocardial injury after non-cardiac surgery (MINS) using preoperative clinical data, biomarkers, and frailty indices.
Interventions
Standard clinical care for major orthopedic surgery including preoperative assessment of biomarkers (hs-cTnT, NT-proBNP), frailty screening (mFI-5), and clinical data collection for the development of a machine learning-based MINS prediction model.
Eligibility Criteria
The study population consists of geriatric patients (aged 65 years) undergoing major orthopedic surgery and requiring postoperative intensive care unit follow-up. Eligible participants must have at least one cardiac troponin level measured within the first 72 hours postoperatively. Patients on chronic dialysis due to end-stage renal disease and those with insufficient preoperative laboratory data will be excluded. The population is selected to represent high-risk geriatric patients in a tertiary training and research hospital setting
You may qualify if:
- All patients aged 65 years and older.
- Patients undergoing major orthopedic surgery (hip fracture repair, total knee/hip arthroplasty, and revision surgeries).
- Patients operated on within the designated study period (January 2021 - December 2023).
- Patients with complete access to preoperative clinical data (comorbidities, medication use) and baseline laboratory parameters (Hemoglobin, Creatinine, Albumin).
- Patients who had at least one postoperative cardiac troponin (hs-cTn) measurement within the first 72 hours after surgery.
You may not qualify if:
- Patients with a documented history of acute myocardial infarction or elevated baseline troponin levels in the preoperative period (to differentiate acute injury from surgical causes).
- Patients with end-stage renal disease (ESRD) requiring dialysis (as chronic kidney dysfunction persistently elevates baseline troponin levels).
- Patients with missing critical preoperative data or incomplete postoperative troponin follow-up.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- DİLEK KALAYCIlead
Study Sites (1)
Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Ankara, Ankara, 06630, Turkey (Türkiye)
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dilek Kalaycı
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Anesthesiology and Reanimation Specialist
Study Record Dates
First Submitted
April 23, 2026
First Posted
May 4, 2026
Study Start
April 1, 2026
Primary Completion (Estimated)
June 1, 2026
Study Completion (Estimated)
June 5, 2026
Last Updated
May 4, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared to ensure patient confidentiality and to comply with institutional data protection policies. However, study results and the final analysis will be made available through peer-reviewed publication